Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Personalized Translational Platform for Biomarker Discovery in Brain Tumors

This study has been completed.
Sponsor:
Collaborators:
Society of Nuclear Medicine and Molecular Imaging
General Electric
Information provided by (Responsible Party):
Marcelo F. Di Carli, MD, FACC, Brigham and Women's Hospital
ClinicalTrials.gov Identifier:
NCT01240161
First received: November 10, 2010
Last updated: August 16, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2016
  Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)